SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer

SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer

Patients with high-grade serous ovarian cancer (HGSOC) have a very poor overall survival. Current therapeutic approaches do not bring benefit to all patients. Although genetic alterations and molecular mechanisms are well characterized, the molecular pathological conditions are poorly investigated....

Full description

Bibliographic Details
Main Authors: Stephanie Koller, Jonatan Kendler, Jasmine Karacs, Andrea Wolf, Caroline Kreuzinger, Isabel Von Der Decken, Felicitas Mungenast, Diana Mechtcheriakova, Wolfgang Schreiner, Andreas Gleiss, Walter Jäger, Dan Cacsire Castillo-Tong, Theresia Thalhammer
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
high-grade serous ovarian cancer
SLCO4A1
OATP4A1
NF-kB
ABCC3
SLCO4A1-AS1
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.946348/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.946348/full

Similar Items